Spyre Therapeutics Inc (SYRE)

Dec 04, 2025

Spyre Therapeutics (NASDAQ:SYRE) CEO Cameron Turtle Sells 15,000 Shares - MarketBeat

Dec 04, 2025

Dec 04, 2025

Will Spyre Therapeutics Inc. (3920) stock see insider accumulationEarnings Overview Report & Fast Momentum Stock Entry Tips - Newser

Dec 04, 2025

Dec 04, 2025

Spyre Therapeutics (NASDAQ:SYRE) Trading Up 7.2%Still a Buy? - MarketBeat

Dec 04, 2025

Dec 03, 2025

Spyre Therapeutics CEO Turtle Cameron sells $435k in stock By Investing.com - Investing.com UK

Dec 03, 2025

Dec 03, 2025

Spyre Therapeutics: A New Era Unfolds? - timothysykes.com

Dec 03, 2025

Dec 03, 2025

A significant driver of top-line growth: Spyre Therapeutics Inc (SYRE) - Setenews

Dec 03, 2025

Dec 03, 2025

Spyre Therapeutics stock reaches 52-week high at 30.56 USD By Investing.com - Investing.com Nigeria

Dec 03, 2025

Dec 03, 2025

Spyre Therapeutics stock reaches 52-week high at 30.56 USD - Investing.com

Dec 03, 2025

Dec 03, 2025

Is Spyre Therapeutics Inc. (3920) stock at risk of policy regulation2025 Valuation Update & Fast Exit and Entry Trade Guides - Newser

Dec 03, 2025

Dec 03, 2025

Why Spyre Therapeutics Inc. stock is in analyst buy zone2025 AllTime Highs & Detailed Earnings Play Strategies - Newser

Dec 03, 2025

Dec 02, 2025

Spyre Therapeutics (NASDAQ:SYRE) Sets New 12-Month High on Analyst Upgrade - MarketBeat

Dec 02, 2025

Dec 02, 2025

Spyre Therapeutics (NASDAQ:SYRE) Upgraded by Jones Trading to Buy Rating - MarketBeat

Dec 02, 2025

Dec 02, 2025

What is the fair value of Spyre Therapeutics Inc. stock nowRate Hike & Verified Momentum Stock Watchlist - Newser

Dec 02, 2025

Dec 02, 2025

Spyre Therapeutics (NASDAQ:SYRE) Upgraded by Jones Trading to “Buy” Rating - Defense World

Dec 02, 2025

Dec 02, 2025

Spyre Therapeutics (NASDAQ:SYRE) Sets New 52-Week High After Analyst Upgrade - Defense World

Dec 02, 2025

Dec 02, 2025

Can Spyre Therapeutics Inc. stock deliver consistent earnings growthMarket Performance Summary & Risk Controlled Swing Alerts - Newser

Dec 02, 2025

Dec 01, 2025

Jones Trading Upgrades Spyre Therapeutics (SYRE) - Nasdaq

Dec 01, 2025

Dec 01, 2025

SYRE Stock Upgraded by Jones Trading; New Price Target Set at $6 - GuruFocus

Dec 01, 2025

Dec 01, 2025

Spyre Therapeutics, Inc. $SYRE Shares Acquired by Franklin Resources Inc. - MarketBeat

Dec 01, 2025

Dec 01, 2025

Spyre Therapeutics, Inc. $SYRE Shares Purchased by Intech Investment Management LLC - Defense World

Dec 01, 2025

Dec 01, 2025

Spyre Therapeutics, Inc. $SYRE Shares Purchased by Geode Capital Management LLC - MarketBeat

Dec 01, 2025

Dec 01, 2025

Spyre stock rating upgraded to Buy at Jones Trading on TL1A blockade potential - Investing.com Canada

Dec 01, 2025

Nov 30, 2025

Nasdaq Composite Tracks Rising Biotech Momentum At Spyre Therapeutics - Kalkine Media

Nov 30, 2025

Nov 27, 2025

What analysts say about Spyre Therapeutics Inc 3920 stockFundamental Stock Analysis & Big Returns Low Cost - earlytimes.in

Nov 27, 2025

Nov 27, 2025

Spyre Therapeutics, Inc. $SYRE Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat

Nov 27, 2025

Nov 26, 2025

A Look at Spyre Therapeutics Inc (SYRE) Shares in the Recent Past Indicates Growth - Setenews

Nov 26, 2025

Nov 26, 2025

Spyre Therapeutics (NASDAQ:SYRE) Reaches New 52-Week HighHere's What Happened - MarketBeat

Nov 26, 2025

Nov 25, 2025

Spyre Therapeutics stock hits 52-week high at 29.1 USD By Investing.com - Investing.com South Africa

Nov 25, 2025

Nov 25, 2025

Spyre Therapeutics stock hits 52-week high at 29.1 USD - Investing.com India

Nov 25, 2025

Nov 21, 2025

Why Spyre Therapeutics Inc. (3920) stock benefits from AI revolutionWeekly Market Outlook & Weekly Stock Performance Updates - newser.com

Nov 21, 2025

Nov 21, 2025

Can Spyre Therapeutics Inc. stock deliver strong Q4 earningsMarket Movers & Fast Entry High Yield Tips - newser.com

Nov 21, 2025

Nov 21, 2025

Is Spyre Therapeutics Inc. (3920) stock worth buying before Fed actionTrend Reversal & Daily Stock Momentum Reports - newser.com

Nov 21, 2025

Nov 20, 2025

Top investors say Spyre Therapeutics Inc (SYRE) ticks everything they need - Setenews

Nov 20, 2025

Nov 19, 2025

Earnings visualization tools for Spyre Therapeutics Inc. - newser.com

Nov 19, 2025

Nov 19, 2025

Will Spyre Therapeutics Inc. (3920) stock recover faster than industryJuly 2025 Patterns & Fast Entry and Exit Trade Plans - newser.com

Nov 19, 2025

Nov 19, 2025

Using data tools to time your Spyre Therapeutics Inc. exit2025 Top Gainers & Safe Entry Momentum Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Why Spyre Therapeutics Inc. stock is seen as undervaluedTrend Reversal & Reliable Entry Point Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Backtesting results for Spyre Therapeutics Inc. trading strategiesQuarterly Portfolio Review & Long-Term Safe Investment Plans - newser.com

Nov 19, 2025

Nov 19, 2025

Will Spyre Therapeutics Inc. (3920) stock announce special dividend2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com

Nov 19, 2025

Nov 19, 2025

Is a relief rally coming for Spyre Therapeutics Inc. holdersQuarterly Investment Review & Free Reliable Trade Execution Plans - newser.com

Nov 19, 2025

Nov 19, 2025

What margin trends mean for Spyre Therapeutics Inc. stock2025 Geopolitical Influence & Verified Momentum Stock Watchlist - newser.com

Nov 19, 2025